Aussie company develops rapid COVID-19 test
The EuGeni COVID-19 Antigen Rapid Test captures both nasal pharyngeal and saliva samples
A new rapid and low-cost COVID-19 test has been developed by an Australian company with the breakthrough expected to be used worldwide.
The EuGeni COVID-19 Antigen Rapid Test captures both nasal pharyngeal and saliva samples, and gives doctors results at the point of care.
It is a single-use, disposable immunochromatographic test that identifies and detects antigen-antibody immune reactions.
The 15-minute test came about as part of the company AnteoTech’s investigation into tests for sepsis, they simply used the same technology to develop an antigen test for COVID-19.
